APAC G-CSF PEG-G-CSF Market - Industry Trends and Forecast to 2030

Description

List of Tables

Asia-Pacific G-CSF/ PEG-G-CSF market is projected to register a substantial CAGR of 6.3% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Asia-Pacific G-CSF/PEG-G-CSF Market, By Indication (Neutropenia, Oncology, Chronic and Autoimmune Disease, Blood Disorders, Growth Harmony Deficiency and Others), Dosage (Mono and Combination), Route Of Administration (Intravenous, Subcuetaneous), Packaging (Single Use Vials and Pre Filled Syringes), End User (Hospitals and Clinics, Research and Academic Institutes, Ambulatory Surgical Centers and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy and Others), Country (China, Japan, India, Australia, New Zealand, Indonesia, Thailand, Vietnam, Singapore, Philippines, Malaysia, Rest of Asia-Pacific) Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the Asia-Pacific G-CSF/PEG-G-CSF market are:

Growing incidences of blood cancers and cancer diseases

Increasing cases of febrile neutropenia

Market Players:

The key market players operating in the Asia-Pacific G-CSF/PEG-G-CSF market are listed below:

Lupin

Gennova Biopharmaceuticals Limited

Reliance Life Sciences

Intas Pharmaceuticals Ltd.

BIOSIDUS

STADA Arzneimittel AG

USV Private Limited

Viatris Inc.

Biocon

Fresenius Kabi AG

Hangzhou Jiuyuan Gene Engineering Co., Ltd.

Amgen Inc.

Pfizer Inc.

Sandoz International GmbH

Apotex Inc.

Cadila Pharmaceuticals

Dr. Reddy's Laboratories Ltd.

Amneal Pharmaceuticals LLC.

Accord Healthcare

NAPP PHARMACEUTICALS LIMITED.

Intas Pharmaceuticals Ltd.

Mundipharma International

Teva Pharmaceutical Industries Ltd.

Spectrum Pharmaceuticals, Inc.

Kyowa Kirin Co., Ltd.

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

1 INTRODUCTION 50

1.1 OBJECTIVES OF THE STUDY 50
1.2 MARKET DEFINITION 50
1.3 OVERVIEW OF ASIA PACIFIC G-CSF / PEG-G-CSF MARKET 50
1.4 LIMITATIONS 52
1.5 MARKETS COVERED 52

2 MARKET SEGMENTATION 55

2.1 MARKETS COVERED 55
2.2 GEOGRAPHICAL SCOPE 56
2.3 YEARS CONSIDERED FOR THE STUDY 57
2.4 CURRENCY AND PRICING 57
2.5 DBMR TRIPOD DATA VALIDATION MODEL 58
2.6 MULTIVARIATE MODELLING 61
2.7 TYPE LIFELINE CURVE 61
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 62
2.9 DBMR MARKET POSITION GRID 63
2.10 MARKET END USER COVERAGE GRID 64
2.11 VENDOR SHARE ANALYSIS 65
2.12 SECONDARY SOURCES 66
2.13 ASSUMPTIONS 66

3 EXECUTIVE SUMMARY 67

4 PREMIUM INSIGHTS 70

4.1 PESTEL ANALYSIS 71
4.2 PORTER'S FIVE FORCES 72
4.3 ASIA PACIFIC G-CSF/PEG-G-CSF MARKET: MERGERS AND ACQUISITION 73
4.4 ASIA PACIFIC G-CSF / PEG-G-CSF MARKET 74
4.5 STRATEGIES TO THE ENTER THE MARKET 74
- 4.5.1 JOINT VENTURE (PARTNERSHIPS): 74
- 4.5.2 ACQUISITION: 74
- 4.5.3 LINE EXPANSION VIA COLLABORATION: 74
- 4.5.4 PRODUCT APPROVAL: 75
- 4.5.5 PRODUCT LAUNCH: 75
- 4.5.6 GEOGRAPHIC EXPANSION: 75
- 4.5.7 COST LEADERSHIP: 76
- 4.5.8 PRODUCT DEVELOPMENT: 76
4.6 ASIA PACIFIC G-CSF / PEG-G-CSF MARKET, INDUSTRY INSIGHTS 77
- 4.6.1 PATENT ANALYSIS 77
- 4.6.2 DRUG TREATMENT RATE BY MATURED MARKETS 78
- 4.6.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES 78
- 4.6.4 THERAPEUTIC ASSESSMENT 78
- 4.6.5 KEY PRICING STRATEGIES 79
- 4.6.6 KEY PATIENT ENROLLMENT STRATEGIES 79
- 4.6.7 CONCLUSION 79
4.7 PIPELINE ANALYSIS FOR ASIA PACIFIC G-CSF / PEG-G-CSF MARKET 80

5 EPIDEMIOLOGY 81

6 ASIA PACIFIC G-CSF / PEG-G-CSF MARKET: REGULATIONS 84

7 MARKET OVERVIEW 87

7.1 DRIVERS 89
- 7.1.1 GROWING INCIDENCES OF BLOOD CANCERS AND CANCER DISEASES 89
- 7.1.2 RISING INCIDENCES OF AUTOIMMUNE DISORDERS 90
- 7.1.3 INCREASING CASES OF FEBRILE NEUTROPENIA 91
- 7.1.4 INCREASING AWARENESS ABOUT FILGRASTIM AND PEGFILGRASTIM 92
7.2 RESTRAIN 93
- 7.2.1 STRINGENT GOVERNMENTAL REGULATIONS 93
- 7.2.2 AVAILABILITY OF ALTERNATIVES FOR THE CHEMOTHERAPY 94
7.3 OPPORTUNITIES 95
- 7.3.1 THE USE OF BIOSIMILARS HELPS REDUCE HEALTHCARE COSTS FOR PATIENTS 95
- 7.3.2 COST-EFFECTIVENESS AND PATENT EXPIRY OF BIOLOGICAL PRODUCTS 95
7.4 CHALLENGES 96
- 7.4.1 THE HIGH COST ASSOCIATED WITH BRANDED BIOLOGICS AND IMPROVED CHEMOTHERAPY 96
- 7.4.2 THE MULTIPLE SIDE EFFECTS OF G-CSF 96

8 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET, BY INDICATION 97

8.1 OVERVIEW 98
8.2 NEUTROPENIA 102
- 8.2.1 CHEMOTHERAPY INDUCED FEBRILE NEUTROPENIA (MYELOSUPPRESSIVE CHEMOTHERAPY TREATMENT) 103
- 8.2.2 SEVERE CHRONIC NEUTROPENIA 103
- 8.2.3 RADIOTHERAPY INDUCED NEUTROPENIA 103
- 8.2.4 NEUTROPENIA IN HIV PATIENTS 103
- 8.2.5 CLOZAPINE INDUCED NEUTROPENIA 103
- 8.2.6 NEUTROPENIA IN HEPATITIS C PATIENTS 103
- 8.2.7 CONGENITAL NEUTROPENIA 103
8.3 ONCOLOGY 104
- 8.3.1 ACUTE MYELOID LEUKEMIA RECEIVING CONSOLIDATION CHEMOTHERAPY 104
- 8.3.2 OTHERS 105
8.4 CHRONIC AND AUTO IMMUNE DISEASES 105
8.5 BLOOD DISORDERS 105
8.6 GROWTH HORMONE DEFICIENCY 106
8.7 OTHERS 107

9 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET, BY DOSAGE 108

9.1 OVERVIEW 109
9.2 MONO 112
9.3 COMBINATION 113

10 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET, BY ROUTE OF ADMINISTRATION 114

10.1 OVERVIEW 115
10.2 SUBCUTANEOUS 118
10.3 INTRAVENOUS 119

11 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET, BY PACKAGING 120

11.1 OVERVIEW 121
11.2 PRE FILLED SYRINGES 124
11.3 SINGLE USE VIALS 125

12 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET, BY END USER 126

12.1 OVERVIEW 127
12.2 HOSPITALS AND CLINICS 130
12.3 RESEARCH & ACADEMIC INSTITUTES 130
12.4 AMBULATORY SURGICAL CENTERS 131
12.5 OTHERS 132

13 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET, BY DISTRIBUTION CHANNEL 133

13.1 OVERVIEW 134
13.2 HOSPITALS PHARMACY 137
13.3 RETAIL PHARMACY 137
13.4 ONLINE PHARMACY 138
13.5 OTHERS 139

14 ASIA PACIFIC G-CSF/PEG-G-CSF MARKET, BY REGION 140

14.1 ASIA-PACIFIC 141
- 14.1.1 CHINA 148
- 14.1.2 INDIA 156
- 14.1.3 INDONESIA 166
- 14.1.4 THAILAND 174
- 14.1.5 VIETNAM 181
- 14.1.6 SINGAPORE 188
- 14.1.7 PHILIPPINES 196
- 14.1.8 MALAYSIA 203

15 ASIA PACIFIC G-CSF / PEG-G-CSF MARKET, COMPANY LANDSCAPE 209

15.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 209

16 SWOT ANALYSIS 210

17 COMPANY PROFILE 211

17.1 PFIZER INC. 211
- 17.1.1 COMPANY SNAPSHOT 211
- 17.1.2 REVENUE ANALYSIS 212
- 17.1.3 COMPANY SHARE ANALYSIS 212
- 17.1.4 PRODUCT PORTFOLIO 213
- 17.1.5 RECENT DEVELOPMENTS 213
17.2 VIATRIS INC. 214
- 17.2.1 COMPANY SNAPSHOT 214
- 17.2.2 REVENUE ANALYSIS 214
- 17.2.3 COMPANY SHARE ANALYSIS 215
- 17.2.4 PRODUCT PORTFOLIO 215
- 17.2.5 RECENT DEVELOPMENT 215
17.3 AMGEN INC. 216
- 17.3.1 COMPANY SNAPSHOT 216
- 17.3.2 REVENUE ANALYSIS 216
- 17.3.3 COMPANY SHARE ANALYSIS 217
- 17.3.4 PRODUCT PORTFOLIO 217
- 17.3.5 RECENT DEVELOPMENTS 217
17.4 STADA ARZENEIMITTEL AG 219
- 17.4.1 COMPANY SNAPSHOT 219
- 17.4.2 COMPANY SHARE ANALYSIS 219
- 17.4.3 PRODUCT PORTFOLIO 220
- 17.4.4 RECENT DEVELOPMENT 220
17.5 TEVA PHARMACEUTICAL INDUSTRIES LTD. 221
- 17.5.1 COMPANY SNAPSHOT 221
- 17.5.2 REVENUE ANALYSIS 221
- 17.5.3 COMPANY SHARE ANALYSIS 222
- 17.5.4 PRODUCT PORTFOLIO 222
- 17.5.5 RECENT DEVELOPMENTS 222
17.6 JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. 223
- 17.6.1 COMPANY SNAPSHOT 223
- 17.6.2 PRODUCT PORTFOLIO 223
- 17.6.3 RECENT DEVELOPMENTS 223
17.7 ACCORD HEALTHCARE 224
- 17.7.1 COMPANY SNAPSHOT 224
- 17.7.2 PRODUCT PORTFOLIO 224
- 17.7.3 RECENT DEVELOPMENTS 224
17.8 AMNEAL PHARMACEUTICALS LLC. 225
- 17.8.1 COMPANY SNAPSHOT 225
- 17.8.2 REVENUE ANALYSIS 225
- 17.8.3 PRODUCT PORTFOLIO 226
- 17.8.4 RECENT DEVELOPMENTS 226
17.9 APOTEX INC. 227
- 17.9.1 COMPANY SNAPSHOT 227
- 17.9.2 PRODUCT PORTFOLIO 227
- 17.9.3 RECENT DEVELOPMENT 227
17.10 BIOCON 228
- 17.10.1 COMPANY SNAPSHOT 228
- 17.10.2 REVENUE ANALYSIS 228
- 17.10.3 PRODUCT PORTFOLIO 229
- 17.10.4 RECENT DEVELOPMENT 229
17.11 BIO SIDUS 230
- 17.11.1 COMPANY SNAPSHOT 230
- 17.11.2 PRODUCT PORTFOLIO 230
- 17.11.3 RECENT DEVELOPMENTS 230
17.12 CADILA PHARMACEUTICALS 231
- 17.12.1 COMPANY SNAPSHOT 231
- 17.12.2 PRODUCT PORTFOLIO 231
- 17.12.3 RECENT DEVELOPMENTS 231
17.13 COHERUS BIOSCIENCES 232
- 17.13.1 COMPANY SNAPSHOT 232
- 17.13.2 REVENUE ANALYSIS 232
- 17.13.3 PRODUCT PORTFOLIO 233
- 17.13.4 RECENT DEVELOPMENT 233
17.14 DR. REDDY'S LABORATORIES LTD 234
- 17.14.1 COMPANY SNAPSHOT 234
- 17.14.2 REVENUE ANALYSIS 234
- 17.14.3 PRODUCT PORTFOLIO 235
- 17.14.4 RECENT DEVELOPMENTS 235
17.15 FRESENIUS KABI AG 236
- 17.15.1 COMPANY SNAPSHOT 236
- 17.15.2 PRODUCT PORTFOLIO 236
- 17.15.3 RECENT DEVELOPMENT 236
17.16 GENNOVA BIOPHARMACEUTICALS LIMITED 237
- 17.16.1 COMPANY SNAPSHOT 237
- 17.16.2 PRODUCT PORTFOLIO 237
- 17.16.3 RECENT DEVELOPMENTS 237
17.17 HANGZHOU JIUYUAN GENE ENGINEERING CO., LTD. 238
- 17.17.1 COMPANY SNAPSHOT 238
- 17.17.2 PRODUCT PORTFOLIO 238
- 17.17.3 RECENT DEVELOPMENTS 238
17.18 INTAS PHARMACEUTICALS LTD. 239
- 17.18.1 COMPANY SNAPSHOT 239
- 17.18.2 PRODUCT PORTFOLIO 239
- 17.18.3 RECENT DEVELOPMENT 239
17.19 KASHIV BIOSCIENCES, LLC. 240
- 17.19.1 COMPANY SNAPSHOT 240
- 17.19.2 PRODUCT PORTFOLIO 240
- 17.19.3 RECENT DEVELOPMENT 240
17.20 KYOWA KIRIN CO., LTD. 241
- 17.20.1 COMPANY SNAPSHOT 241
- 17.20.2 REVENUE ANALYSIS 241
- 17.20.3 PRODUCT PORTFOLIO 242
- 17.20.4 RECENT DEVELOPMENT 242
17.21 LUPIN 243
- 17.21.1 COMPANY SNAPSHOT 243
- 17.21.2 REVENUE ANALYSIS 243
- 17.21.3 PRODUCT PORTFOLIO 244
- 17.21.4 RECENT DEVELOPMENT 244
17.22 MUNDIPHARMA INTERNATIONAL. 245
- 17.22.1 COMPANY SNAPSHOT 245
- 17.22.2 PRODUCT PORTFOLIO 245
- 17.22.3 RECENT DEVELOPMENT 245
17.23 NAPP PHARMACEUTICALS LIMITED 246
- 17.23.1 COMPANY SNAPSHOT 246
- 17.23.2 PRODUCT PORTFOLIO 246
- 17.23.3 RECENT DEVELOPMENT 246
17.24 RELIANCE LIFE SCIENCES 247
- 17.24.1 COMPANY SNAPSHOT 247
- 17.24.2 PRODUCT PORTFOLIO 247
- 17.24.3 RECENT DEVELOPMENTS 247
17.25 SANDOZ INTERNATIONAL GMBH 248
- 17.25.1 COMPANY SNAPSHOT 248
- 17.25.2 REVENUE ANALYSIS 248
- 17.25.3 PRODUCT PORTFOLIO 249
- 17.25.4 RECENT DEVELOPMENTS 249
17.26 SPECTRUM PHARMACEUTICALS, INC. 250
- 17.26.1 COMPANY SNAPSHOT 250
- 17.26.2 PRODUCT PORTFOLIO 250
- 17.26.3 RECENT DEVELOPMENT 250
17.27 USV PRIVATE LIMITED 251
- 17.27.1 COMPANY SNAPSHOT 251
- 17.27.2 PRODUCT PORTFOLIO 251
- 17.27.3 RECENT DEVELOPMENTS 251

18 QUESTIONNAIRE 252

19 RELATED REPORTS 255

LIST OF TABLES

TABLE 1 BELOW ARE THE RULES AND REGULATIONS TO GET APPROVAL FOR USE IN THE MARKET: 60
TABLE 2 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET, BY INDICATION, 2021-2030 (USD MILLION) 77
TABLE 3 ASIA PACIFIC NEUTROPENIA IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 78
TABLE 4 ASIA PACIFIC NEUTROPENIA IN G-CSF/ PEG-G-CSF MARKET, BY INDICATION, 2021-2030 (USD MILLION) 78
TABLE 5 ASIA PACIFIC ONCOLOGY IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 80
TABLE 6 ASIA PACIFIC ONCOLOGY IN G-CSF/ PEG-G-CSF MARKET, BY INDICATION, 2021-2030 (USD MILLION) 80
TABLE 7 ASIA PACIFIC CHRONIC AND AUTO IMMUNE DISEASES IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 81
TABLE 8 ASIA PACIFIC BLOOD DISORDERS IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 82
TABLE 9 ASIA PACIFIC GROWTH HORMONE DEFICIENCY IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 82
TABLE 10 ASIA PACIFIC OTHERS IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 83
TABLE 11 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET, BY DOSAGE, 2020-2029 (USD MILLION) 87
TABLE 12 ASIA PACIFIC MONO IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 88
TABLE 13 ASIA PACIFIC COMBINATION IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 89
TABLE 14 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION) 93
TABLE 15 ASIA PACIFIC SUBCUTANEOUS IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 94
TABLE 16 ASIA PACIFIC INTRAVENOUS IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 95
TABLE 17 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET, BY PACKAGING, 2020-2029 (USD MILLION) 99
TABLE 18 ASIA PACIFIC PRE FILLED SYRINGES IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 100
TABLE 19 ASIA PACIFIC SINGLE USE VIALS IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 101
TABLE 20 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET, BY END USER, 2020-2029 (USD MILLION) 105
TABLE 21 ASIA PACIFIC HOSPITALS AND CLINICS IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 106
TABLE 22 ASIA PACIFIC RESEARCH & ACADEMIC INSTITUTES IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 107
TABLE 23 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN G-CSF/ PEG-G-CSFMARKET, BY REGION, 2020-2029 (USD MILLION) 107
TABLE 24 ASIA PACIFIC OTHERS IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 108
TABLE 25 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 112
TABLE 26 ASIA PACIFIC HOSPITALS PHARMACY IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 113
TABLE 27 ASIA PACIFIC RETAIL PHARMACY IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 114
TABLE 28 ASIA PACIFIC ONLINE PHARMACY IN G-CSF/ PEG-G-CSFMARKET, BY REGION, 2020-2029 (USD MILLION) 114
TABLE 29 ASIA PACIFIC OTHERS IN G-CSF/ PEG-G-CSF MARKET, BY REGION, 2020-2029 (USD MILLION) 115
TABLE 30 ASIA-PACIFIC G-CSF / PEG-G-CSF MARKET, 2020-2030 (USD MILLION) 120
TABLE 31 ASIA-PACIFIC G-CSF / PEG-G-CSF MARKET, 2020-2030 (USD MILLION) 120
TABLE 32 ASIA-PACIFIC G-CSF / PEG-G-CSF MARKET, BY COUNTRY, 2020-2030 (USD MILLION) 120
TABLE 33 ASIA-PACIFIC G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 121
TABLE 34 ASIA-PACIFIC NEUTROPENIA IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 121
TABLE 35 ASIA-PACIFIC ONCOLOGY IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 121
TABLE 36 ASIA-PACIFIC G-CSF / PEG-G-CSF MARKET, BY DOSAGE, 2020-2030 (USD MILLION) 122
TABLE 37 ASIA-PACIFIC G-CSF / PEG-G-CSF MARKET, BY ROUTE OF ADMINISTRATION, 2020-2030 (USD MILLION) 122
TABLE 38 ASIA-PACIFIC G-CSF / PEG-G-CSF MARKET, BY PACKAGING, 2020-2030 (USD MILLION) 122
TABLE 39 ASIA-PACIFIC G-CSF / PEG-G-CSF MARKET, BY END USER, 2020-2030 (USD MILLION) 122
TABLE 40 ASIA-PACIFIC G-CSF / PEG-G-CSF MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 (USD MILLION) 123
TABLE 41 CHINA G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 124
TABLE 42 CHINA NEUTROPENIA IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 124
TABLE 43 CHINA ONCOLOGY IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 125
TABLE 44 CHINA G-CSF / PEG-G-CSF MARKET, BY DOSAGE, 2020-2030 (USD MILLION) 125
TABLE 45 CHINA MONO IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 125
TABLE 46 CHINA G-CSF / PEG-G-CSF MARKET, BY ROUTE OF ADMINISTRATION, 2020-2030 (USD MILLION) 125
TABLE 47 CHINA SUBCUTANEOUS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 126
TABLE 48 CHINA PRE FILLED SYRINGES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 126
TABLE 49 CHINA G-CSF / PEG-G-CSF MARKET, BY END USER, 2020-2030 (USD MILLION) 126
TABLE 50 CHINA HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 127
TABLE 51 CHINA HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 127
TABLE 52 CHINA RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 127
TABLE 53 CHINA RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 128
TABLE 54 CHINA RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 128
TABLE 55 CHINA AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 128
TABLE 56 CHINA AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 128
TABLE 57 CHINA AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 128
TABLE 58 CHINA G-CSF / PEG-G-CSF MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 (USD MILLION) 129
TABLE 59 CHINA HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 129
TABLE 60 CHINA HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 129
TABLE 61 CHINA HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 129
TABLE 62 CHINA RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 130
TABLE 63 CHINA RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 130
TABLE 64 CHINA RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 130
TABLE 65 CHINA ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 130
TABLE 66 CHINA ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 131
TABLE 67 CHINA ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 131
TABLE 68 INDIA G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 132
TABLE 69 INDIA NEUTROPENIA IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 132
TABLE 70 INDIA ONCOLOGY IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 133
TABLE 71 INDIA G-CSF / PEG-G-CSF MARKET, BY DOSAGE, 2020-2030 (USD MILLION) 133
TABLE 72 INDIA MONO IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 133
TABLE 73 INDIA COMBINATION IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 133
TABLE 74 INDIA G-CSF / PEG-G-CSF MARKET, BY ROUTE OF ADMINISTRATION, 2020-2030 (USD MILLION) 134
TABLE 75 INDIA SUBCUTANEOUS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 134
TABLE 76 INDIA G-CSF / PEG-G-CSF MARKET, BY PACKAGING, 2020-2030 (USD MILLION) 134
TABLE 77 INDIA PRE FILLED SYRINGES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 134
TABLE 78 INDIA G-CSF / PEG-G-CSF MARKET, BY END USER, 2020-2030 (USD MILLION) 135
TABLE 79 INDIA HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 135
TABLE 80 INDIA HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 135
TABLE 81 INDIA HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 136
TABLE 82 INDIA RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 136
TABLE 83 INDIA RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 136
TABLE 84 INDIA RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 137
TABLE 85 INDIA AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 137
TABLE 86 INDIA AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 137
TABLE 87 INDIA AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 138
TABLE 88 INDIA G-CSF / PEG-G-CSF MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 (USD MILLION) 138
TABLE 89 INDIA HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 138
TABLE 90 INDIA HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 139
TABLE 91 INDIA HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 139
TABLE 92 INDIA RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 139
TABLE 93 INDIA RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 140
TABLE 94 INDIA RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 140
TABLE 95 INDIA ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 140
TABLE 96 INDIA ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 141
TABLE 97 INDIA ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 141
TABLE 98 INDONESIA G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 142
TABLE 99 INDONESIA NEUTROPENIA IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 142
TABLE 100 INDONESIA ONCOLOGY IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 143
TABLE 101 INDONESIA G-CSF / PEG-G-CSF MARKET, BY DOSAGE, 2020-2030 (USD MILLION) 143
TABLE 102 INDONESIA MONO IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 143
TABLE 103 INDONESIA G-CSF / PEG-G-CSF MARKET, BY ROUTE OF ADMINISTRATION, 2020-2030 (USD MILLION) 143
TABLE 104 INDONESIA SUBCUTANEOUS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 144
TABLE 105 INDONESIA INTRAVENOUS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 144
TABLE 106 INDONESIA G-CSF / PEG-G-CSF MARKET, BY PACKAGING, 2020-2030 (USD MILLION) 144
TABLE 107 INDONESIA PRE FILLED SYRINGES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 144
TABLE 108 INDONESIA SINGLE USE VIALS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 145
TABLE 109 INDONESIA G-CSF / PEG-G-CSF MARKET, BY END USER, 2020-2030 (USD MILLION) 145
TABLE 110 INDONESIA HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 145
TABLE 111 INDONESIA HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 145
TABLE 112 INDONESIA HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 146
TABLE 113 INDONESIA RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 146
TABLE 114 INDONESIA RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 146
TABLE 115 INDONESIA RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 146
TABLE 116 INDONESIA AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 146
TABLE 117 INDONESIA AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 147
TABLE 118 INDONESIA AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 147
TABLE 119 INDONESIA G-CSF / PEG-G-CSF MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 (USD MILLION) 147
TABLE 120 INDONESIA HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 147
TABLE 121 INDONESIA HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 148
TABLE 122 INDONESIA HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 148
TABLE 123 INDONESIA RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 148
TABLE 124 INDONESIA RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 148
TABLE 125 INDONESIA RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 148
TABLE 126 INDONESIA ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 148
TABLE 127 INDONESIA ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 149
TABLE 128 INDONESIA ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 149
TABLE 129 THAILAND G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 150
TABLE 130 THAILAND NEUTROPENIA IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 150
TABLE 131 THAILAND ONCOLOGY IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 151
TABLE 132 THAILAND G-CSF / PEG-G-CSF MARKET, BY DOSAGE, 2020-2030 (USD MILLION) 151
TABLE 133 THAILAND MONO IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 151
TABLE 134 THAILAND G-CSF / PEG-G-CSF MARKET, BY ROUTE OF ADMINISTRATION, 2020-2030 (USD MILLION) 151
TABLE 135 THAILAND SUBCUTANEOUS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 152
TABLE 136 THAILAND G-CSF / PEG-G-CSF MARKET, BY PACKAGING, 2020-2030 (USD MILLION) 152
TABLE 137 THAILAND PRE FILLED SYRINGES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 152
TABLE 138 THAILAND G-CSF / PEG-G-CSF MARKET, BY END USER, 2020-2030 (USD MILLION) 152
TABLE 139 THAILAND HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 153
TABLE 140 THAILAND HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 153
TABLE 141 THAILAND HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 153
TABLE 142 THAILAND RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 153
TABLE 143 THAILAND RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 153
TABLE 144 THAILAND RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 154
TABLE 145 THAILAND AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 154
TABLE 146 THAILAND AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 154
TABLE 147 THAILAND AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 154
TABLE 148 THAILAND G-CSF / PEG-G-CSF MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 (USD MILLION) 154
TABLE 149 THAILAND HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 155

TABLE 150 THAILAND HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 155
TABLE 151 THAILAND HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 155
TABLE 152 THAILAND RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 155
TABLE 153 THAILAND RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 155
TABLE 154 THAILAND RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 156
TABLE 155 THAILAND ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 156
TABLE 156 THAILAND ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 156
TABLE 157 THAILAND ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 156
TABLE 158 VIETNAM G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 157
TABLE 159 VIETNAM NEUTROPENIA IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 157
TABLE 160 VIETNAM ONCOLOGY IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 158
TABLE 161 VIETNAM G-CSF / PEG-G-CSF MARKET, BY DOSAGE, 2020-2030 (USD MILLION) 158
TABLE 162 VIETNAM MONO IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 158
TABLE 163 VIETNAM G-CSF / PEG-G-CSF MARKET, BY ROUTE OF ADMINISTRATION, 2020-2030 (USD MILLION) 158
TABLE 164 VIETNAM SUBCUTANEOUS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 159
TABLE 165 VIETNAM G-CSF / PEG-G-CSF MARKET, BY PACKAGING, 2020-2030 (USD MILLION) 159
TABLE 166 VIETNAM PRE FILLED SYRINGES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 159
TABLE 167 VIETNAM G-CSF / PEG-G-CSF MARKET, BY END USER, 2020-2030 (USD MILLION) 159
TABLE 168 VIETNAM HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 160
TABLE 169 VIETNAM HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 160
TABLE 170 VIETNAM HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 160
TABLE 171 VIETNAM RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 160
TABLE 172 VIETNAM RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 160
TABLE 173 VIETNAM RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 161
TABLE 174 VIETNAM AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 161
TABLE 175 VIETNAM AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 161
TABLE 176 VIETNAM AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 161
TABLE 177 VIETNAM G-CSF / PEG-G-CSF MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 (USD MILLION) 161
TABLE 178 VIETNAM HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 162
TABLE 179 VIETNAM HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 162
TABLE 180 VIETNAM HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 162
TABLE 181 VIETNAM RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 162
TABLE 182 VIETNAM RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 163
TABLE 183 VIETNAM RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 163
TABLE 184 VIETNAM ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 163
TABLE 185 VIETNAM ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 163
TABLE 186 VIETNAM ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 163
TABLE 187 SINGAPORE G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 164
TABLE 188 SINGAPORE NEUTROPENIA IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 164
TABLE 189 SINGAPORE ONCOLOGY IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 165
TABLE 190 SINGAPORE G-CSF / PEG-G-CSF MARKET, BY DOSAGE, 2020-2030 (USD MILLION) 165
TABLE 191 SINGAPORE MONO IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 165
TABLE 192 SINGAPORE G-CSF / PEG-G-CSF MARKET, BY ROUTE OF ADMINISTRATION, 2020-2030 (USD MILLION) 165
TABLE 193 SINGAPORE SUBCUTANEOUS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 166
TABLE 194 SINGAPORE INTRAVENOUS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 166
TABLE 195 SINGAPORE G-CSF / PEG-G-CSF MARKET, BY PACKAGING, 2020-2030 (USD MILLION) 166
TABLE 196 SINGAPORE PRE FILLED SYRINGES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 166
TABLE 197 SINGAPORE SINGLE USE VIALS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 167
TABLE 198 SINGAPORE G-CSF / PEG-G-CSF MARKET, BY END USER, 2020-2030 (USD MILLION) 167
TABLE 199 SINGAPORE HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 167
TABLE 200 SINGAPORE HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 167
TABLE 201 SINGAPORE HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 168
TABLE 202 SINGAPORE RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 168
TABLE 203 SINGAPORE RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 168
TABLE 204 SINGAPORE RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 168
TABLE 205 SINGAPORE AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 168
TABLE 206 SINGAPORE AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 169
TABLE 207 SINGAPORE AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 169
TABLE 208 SINGAPORE G-CSF / PEG-G-CSF MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 (USD MILLION) 169
TABLE 209 SINGAPORE HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 169
TABLE 210 SINGAPORE HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 170
TABLE 211 SINGAPORE HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 170
TABLE 212 SINGAPORE RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 170
TABLE 213 SINGAPORE RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 170
TABLE 214 SINGAPORE RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 170
TABLE 215 SINGAPORE ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 171
TABLE 216 SINGAPORE ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 171
TABLE 217 SINGAPORE ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 171
TABLE 218 PHILIPPINES G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 172
TABLE 219 PHILIPPINES NEUTROPENIA IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 172
TABLE 220 PHILIPPINES ONCOLOGY IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 173
TABLE 221 PHILIPPINES G-CSF / PEG-G-CSF MARKET, BY DOSAGE, 2020-2030 (USD MILLION) 173
TABLE 222 PHILIPPINES MONO IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 173
TABLE 223 PHILIPPINES G-CSF / PEG-G-CSF MARKET, BY ROUTE OF ADMINISTRATION, 2020-2030 (USD MILLION) 173
TABLE 224 PHILIPPINES SUBCUTANEOUS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 174
TABLE 225 PHILIPPINES G-CSF / PEG-G-CSF MARKET, BY PACKAGING, 2020-2030 (USD MILLION) 174
TABLE 226 PHILIPPINES PRE FILLED SYRINGES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 174
TABLE 227 PHILIPPINES G-CSF / PEG-G-CSF MARKET, BY END USER, 2020-2030 (USD MILLION) 174
TABLE 228 PHILIPPINES HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 175
TABLE 229 PHILIPPINES HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 175
TABLE 230 PHILIPPINES HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 175
TABLE 231 PHILIPPINES RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 175
TABLE 232 PHILIPPINES RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 175
TABLE 233 PHILIPPINES RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 176
TABLE 234 PHILIPPINES AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 176
TABLE 235 PHILIPPINES AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 176
TABLE 236 PHILIPPINES AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 176
TABLE 237 PHILIPPINES G-CSF / PEG-G-CSF MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 (USD MILLION) 176
TABLE 238 PHILIPPINES HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 177
TABLE 239 PHILIPPINES HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 177
TABLE 240 PHILIPPINES HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 177
TABLE 241 PHILIPPINES RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 177
TABLE 242 PHILIPPINES RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 178
TABLE 243 PHILIPPINES RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 178
TABLE 244 PHILIPPINES ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 178
TABLE 245 PHILIPPINES ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 178
TABLE 246 PHILIPPINES ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 178
TABLE 247 MALAYSIA G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 179
TABLE 248 MALAYSIA NEUTROPENIA IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 179
TABLE 249 MALAYSIA ONCOLOGY IN G-CSF / PEG-G-CSF MARKET, BY INDICATION, 2020-2030 (USD MILLION) 179
TABLE 250 MALAYSIA G-CSF / PEG-G-CSF MARKET, BY DOSAGE, 2020-2030 (USD MILLION) 180
TABLE 251 MALAYSIA MONO IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 180
TABLE 252 MALAYSIA G-CSF / PEG-G-CSF MARKET, BY ROUTE OF ADMINISTRATION, 2020-2030 (USD MILLION) 180
TABLE 253 MALAYSIA SUBCUTANEOUS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 180
TABLE 254 MALAYSIA G-CSF / PEG-G-CSF MARKET, BY PACKAGING, 2020-2030 (USD MILLION) 180
TABLE 255 MALAYSIA PRE FILLED SYRINGES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 180
TABLE 256 MALAYSIA G-CSF / PEG-G-CSF MARKET, BY END USER, 2020-2030 (USD MILLION) 181
TABLE 257 MALAYSIA HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 181
TABLE 258 MALAYSIA HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 181
TABLE 259 MALAYSIA HOSPITAL AND CLINICS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 181
TABLE 260 MALAYSIA RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 182
TABLE 261 MALAYSIA RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 182
TABLE 262 MALAYSIA RESEARCH AND ACADEMIC INSTITUTES IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 182
TABLE 263 MALAYSIA AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 182
TABLE 264 MALAYSIA AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 182
TABLE 265 MALAYSIA AMBULATORY SURGICAL CENTERS IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 182
TABLE 266 MALAYSIA G-CSF / PEG-G-CSF MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 (USD MILLION) 183
TABLE 267 MALAYSIA HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 183
TABLE 268 MALAYSIA HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 183
TABLE 269 MALAYSIA HOSPITAL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 183
TABLE 270 MALAYSIA RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 183
TABLE 271 MALAYSIA RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 184
TABLE 272 MALAYSIA RETAIL PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 184
TABLE 273 MALAYSIA ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 (USD MILLION) 184
TABLE 274 MALAYSIA ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 ASP (USD) 184
TABLE 275 MALAYSIA ONLINE PHARMACY IN G-CSF / PEG-G-CSF MARKET, BY BRAND, 2020-2030 VOLUME (UNITS) 184

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC G-CSF / PEG-G-CSF MARKET: SEGMENTATION 30
FIGURE 2 ASIA PACIFIC G-CSF / PEG-G-CSF MARKET: DATA TRIANGULATION 33
FIGURE 3 ASIA PACIFIC G-CSF / PEG-G-CSF MARKET: DROC ANALYSIS 34
FIGURE 4 ASIA PACIFIC G-CSF / PEG-G-CSF MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 35
FIGURE 5 ASIA PACIFIC G-CSF / PEG-G-CSF MARKET: COMPANY RESEARCH ANALYSIS 35
FIGURE 6 ASIA PACIFIC G-CSF / PEG-G-CSF MARKET: INTERVIEW DEMOGRAPHICS 37
FIGURE 7 ASIA PACIFIC G-CSF / PEG-G-CSF MARKET: DBMR MARKET POSITION GRID 38
FIGURE 8 ASIA PACIFIC G-CSF / PEG-G-CSF MARKET: MARKET END USER COVERAGE GRID 39
FIGURE 9 ASIA PACIFIC G-CSF / PEG-G-CSF MARKET: VENDOR SHARE ANALYSIS 40
FIGURE 10 ASIA PACIFIC G-CSF / PEG-G-CSF MARKET: SEGMENTATION 44
FIGURE 11 THE INCREASE IN CANCER PROPHYLAXIS IN DEVELOPED COUNTRIES AND INITIATIVES TAKEN BY GOVERNMENTS ARE TO DRIVE THE ASIA PACIFIC G-CSF / PEG-G-CSF MARKET FROM 2023 TO 2030 45
FIGURE 12 NEUTROPENIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC G-CSF / PEG-G-CSF MARKET IN 2023 & 2030 45
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC G-CSF / PEG-G-CSF MARKET 63
FIGURE 14 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY INDICATION CATEGORY, 2022 74
FIGURE 15 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY INDICATION CATEGORY, 2021-2030 (USD MILLION) 75
FIGURE 16 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY INDICATION CATEGORY, CAGR (2022-2029) 75
FIGURE 17 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY INDICATION CATEGORY, LIFELINE CURVE 76
FIGURE 18 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY DOSAGE, 2022 84
FIGURE 19 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY DOSAGE, 2021-2030 (USD MILLION) 85
FIGURE 20 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY DOSAGE, CAGR (2023-2030) 85
FIGURE 21 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY DOSAGE, LIFELINE CURVE 86
FIGURE 22 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY ROUTE OF ADMINISTRATION, 2022 90
FIGURE 23 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION) 91
FIGURE 24 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030) 91
FIGURE 25 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE 92
FIGURE 26 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY PACKAGING, 2022 96
FIGURE 27 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY PACKAGING, 2021-2030 (USD MILLION) 97
FIGURE 28 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY PACKAGING, CAGR (2023-2030) 97
FIGURE 29 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY PACKAGING, LIFELINE CURVE 98
FIGURE 30 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY END USER, 2022 102
FIGURE 31 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY END USER, 2021-2030 (USD MILLION) 103
FIGURE 32 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY END USER, CAGR (2023-2030) 103
FIGURE 33 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY END USER, LIFELINE CURVE 104
FIGURE 34 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY DISTRIBUTION CHANNEL, 2022 109
FIGURE 35 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 110
FIGURE 36 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 110
FIGURE 37 ASIA PACIFIC G-CSF/ PEG-G-CSF MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 111
FIGURE 38 ASIA-PACIFIC G-CSF/PEG-G-CSF MARKET: SNAPSHOT (2022) 116
FIGURE 39 ASIA-PACIFIC G-CSF/PEG-G-CSF MARKET: BY COUNTRY (2022) 117
FIGURE 40 ASIA-PACIFIC G-CSF/PEG-G-CSF MARKET: BY COUNTRY (2022 & 2030) 117
FIGURE 41 ASIA-PACIFIC G-CSF/PEG-G-CSF MARKET: BY COUNTRY (2022 & 2030) 118
FIGURE 42 ASIA-PACIFIC G-CSF/PEG-G-CSF MARKET: BY INDICATION (2023-2030) 118
FIGURE 43 ASIA PACIFIC G-CSF / PEG-G-CSF MARKET: COMPANY SHARE 2022 (%) 184